{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:58:18Z","timestamp":1793825898963,"version":"4.6.1"},"reference-count":236,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40265-026-02326-w","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:27:43Z","timestamp":1780028863000},"page":"1261-1284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex-Biased Pharmacotherapeutic Disparities in Hypertension"],"prefix":"10.1007","volume":"86","author":[{"given":"Serge","family":"Yaacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Bardawil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Yammine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Dakroub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3004-5675","authenticated-orcid":false,"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"4","key":"2326_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"key":"2326_CR2","doi-asserted-by":"crossref","unstructured":"Chapter 13. Secondary hypertension. Hypertens Res. 2014;37(4):349\u201361.","DOI":"10.1038\/hr.2014.16"},{"key":"2326_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/eurjcn\/zvae004","author":"G Lee","year":"2024","unstructured":"Lee G. Hypertension: The silent killer in a vulnerable population. Eur J Cardiovasc Nurs. 2024. https:\/\/doi.org\/10.1093\/eurjcn\/zvae004.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"49","key":"2326_CR4","first-page":"866","volume":"107","author":"RE Schmieder","year":"2010","unstructured":"Schmieder RE. End organ damage in hypertension. Dtsch Arztebl Int. 2010;107(49):866\u201373.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"2326_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cnc.2018.11.008","volume":"31","author":"SL Rivera","year":"2019","unstructured":"Rivera SL, Martin J, Landry J. Acute and chronic hypertension: what clinicians need to know for diagnosis and\u00a0management. Crit Care Nurs Clin N Am. 2019;31(1):97\u2013108.","journal-title":"Crit Care Nurs Clin N Am"},{"issue":"1","key":"2326_CR6","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"S Oparil","year":"2018","unstructured":"Oparil S, et al. Hypertension. Nat Rev Dis Primers. 2018;4(1):18014.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2326_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13054-018-1962-8","volume":"22","author":"EH Post","year":"2018","unstructured":"Post EH, Vincent J-L. Renal autoregulation and blood pressure management in circulatory shock. Crit Care. 2018;22(1):81.","journal-title":"Crit Care"},{"issue":"7","key":"2326_CR8","first-page":"437","volume":"19","author":"JC Dussaule","year":"1998","unstructured":"Dussaule JC, et al. Interactions between the renin-angiotensin system, nitric oxide and endothelin. Nephrologie. 1998;19(7):437\u201341.","journal-title":"Nephrologie"},{"issue":"5","key":"2326_CR9","first-page":"659","volume":"32","author":"A Harvey","year":"2016","unstructured":"Harvey A, et al. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol. 2016;32(5):659\u201368.","journal-title":"Can J Cardiol"},{"issue":"12","key":"2326_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31424","volume":"239","author":"L Ghanem","year":"2024","unstructured":"Ghanem L, et al. Phenotypic switch of vascular smooth muscle cells in COVID-19: role of cholesterol, calcium, and phosphate. J Cell Physiol. 2024;239(12):e31424.","journal-title":"J Cell Physiol"},{"issue":"4","key":"2326_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31200","volume":"239","author":"M Elmarasi","year":"2024","unstructured":"Elmarasi M, et al. Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection. J Cell Physiol. 2024;239(4):e31200.","journal-title":"J Cell Physiol"},{"key":"2326_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228764","author":"A Badran","year":"2020","unstructured":"Badran A, et al. Reactive oxygen species: Modulators of phenotypic switch of vascular smooth muscle cells. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21228764.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2326_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11906-022-01183-8","volume":"24","author":"PJ Connelly","year":"2022","unstructured":"Connelly PJ, Currie G, Delles C. Sex differences in the prevalence, outcomes and management of hypertension. Curr Hypertens Rep. 2022;24(6):185\u201392.","journal-title":"Curr Hypertens Rep"},{"issue":"8","key":"2326_CR14","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254\u2013743.","journal-title":"Circulation"},{"issue":"2","key":"2326_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0025-6196(11)63649-5","volume":"73","author":"SN Hayes","year":"1998","unstructured":"Hayes SN, Taler SJ. Hypertension in women: current understanding of gender differences. Mayo Clin Proc. 1998;73(2):157\u201365.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"2326_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41371-023-00801-5","volume":"37","author":"JE Bager","year":"2023","unstructured":"Bager JE, et al. Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care. J Hum Hypertens. 2023;37(8):662\u201370.","journal-title":"J Hum Hypertens"},{"issue":"7","key":"2326_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/CIRCULATIONAHA.120.049360","volume":"143","author":"H Ji","year":"2021","unstructured":"Ji H, et al. Sex differences in blood pressure associations with cardiovascular outcomes. Circulation. 2021;143(7):761\u20133.","journal-title":"Circulation"},{"issue":"1","key":"2326_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2042-6410-3-7","volume":"3","author":"K Sandberg","year":"2012","unstructured":"Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3(1):7.","journal-title":"Biol Sex Differ"},{"issue":"3","key":"2326_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamacardio.2019.5306","volume":"5","author":"H Ji","year":"2020","unstructured":"Ji H, et al. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol. 2020;5(3):19\u201326.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"2326_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1113\/EP085146","volume":"101","author":"MJ Joyner","year":"2016","unstructured":"Joyner MJ, Wallin BG, Charkoudian N. Sex differences and blood pressure regulation in humans. Exp Physiol. 2016;101(3):349\u201355.","journal-title":"Exp Physiol"},{"issue":"11","key":"2326_CR21","first-page":"825","volume":"102","author":"AA Merz","year":"2016","unstructured":"Merz AA, Cheng S. Sex differences in cardiovascular ageing. Heart Br Card Soc. 2016;102(11):825\u201331.","journal-title":"Heart Br Card Soc"},{"issue":"47","key":"2326_CR22","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","volume":"40","author":"CSP Lam","year":"2019","unstructured":"Lam CSP, et al. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859\u20133868c.","journal-title":"Eur Heart J"},{"issue":"4","key":"2326_CR23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCRESAHA.121.319902","volume":"130","author":"H Ji","year":"2022","unstructured":"Ji H, et al. Sex differences in myocardial and vascular aging. Circ Res. 2022;130(4):566\u201377.","journal-title":"Circ Res"},{"issue":"7","key":"2326_CR24","first-page":"473","volume":"38","author":"F Crea","year":"2016","unstructured":"Crea F, et al. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J. 2016;38(7):473\u20137.","journal-title":"Eur Heart J"},{"issue":"2","key":"2326_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.15171\/jcvtr.2019.20","volume":"11","author":"Y Veisani","year":"2019","unstructured":"Veisani Y, et al. The role of socio-economic inequality in the prevalence of hypertension in adults. J Cardiovasc Thorac Res. 2019;11(2):116\u201320.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"2","key":"2326_CR26","first-page":"223","volume":"35","author":"AG Cuevas","year":"2017","unstructured":"Cuevas AG, Williams DR, Albert MA. Psychosocial factors and hypertension. Cardiol Clin. 2017;35(2):223\u201330.","journal-title":"Cardiol Clin"},{"key":"2326_CR27","doi-asserted-by":"crossref","unstructured":"Dal Canto E, et al. Sex differences in the prescription of anti-hypertensive medications in primary care patients. BJGP Open. 2025:BJGPO.2024.0116.","DOI":"10.3399\/BJGPO.2024.0116"},{"issue":"8","key":"2326_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.29764","volume":"7","author":"MM Blazel","year":"2024","unstructured":"Blazel MM, et al. Neighborhood-level disparities in hypertension prevalence and treatment among middle-aged adults. JAMA Netw Open. 2024;7(8):e2429764.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2326_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","volume":"24","author":"K Komukai","year":"2010","unstructured":"Komukai K, Mochizuki S, Yoshimura M. Gender and the renin\u2013angiotensin\u2013aldosterone system. Fundam Clin Pharmacol. 2010;24(6):687\u201398.","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"2326_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.endien.2022.01.005","volume":"69","author":"RA Vargas Vargas","year":"2022","unstructured":"Vargas Vargas RA, Varela Mill\u00e1n JM, Fajardo Bonilla E. Renin\u2013angiotensin system: basic and clinical aspects\u2014a general perspective. Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed). 2022;69(1):52\u201362.","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"},{"issue":"1","key":"2326_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00424-012-1126-7","volume":"465","author":"UG Friis","year":"2013","unstructured":"Friis UG, et al. Regulation of renin secretion by renal juxtaglomerular cells. Pflugers Arch. 2013;465(1):25\u201337.","journal-title":"Pflugers Arch"},{"issue":"12","key":"2326_CR32","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/s41440-022-01033-9","volume":"45","author":"T Senbonmatsu","year":"2022","unstructured":"Senbonmatsu T. Prorenin: what are its functions? Hypertens Res. 2022;45(12):2021\u20133.","journal-title":"Hypertens Res"},{"issue":"7","key":"2326_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/hr.2016.17","volume":"39","author":"H Lu","year":"2016","unstructured":"Lu H, et al. Structure and functions of angiotensinogen. Hypertens Res. 2016;39(7):492\u2013500.","journal-title":"Hypertens Res"},{"issue":"7","key":"2326_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/emmm.201000080","volume":"2","author":"A Benigni","year":"2010","unstructured":"Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247\u201357.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"2326_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/08037050310001057","volume":"12","author":"E Kaschina","year":"2003","unstructured":"Kaschina E, Unger T. Angiotensin AT1\/AT2 receptors: regulation, signalling and function. Blood Press. 2003;12(2):70\u201388.","journal-title":"Blood Press"},{"issue":"5","key":"2326_CR36","doi-asserted-by":"publisher","first-page":"R498","DOI":"10.1152\/ajpregu.00182.2014","volume":"307","author":"E O'Donnell","year":"2014","unstructured":"O\u2019Donnell E, Floras JS, Harvey PJ. Estrogen status and the renin angiotensin aldosterone system. Am J Physiol Regul Integr Comp Physiol. 2014;307(5):R498\u2013500.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"2326_CR37","doi-asserted-by":"publisher","first-page":"15772","DOI":"10.1038\/s41598-018-34049-8","volume":"8","author":"K Domi\u0144ska","year":"2018","unstructured":"Domi\u0144ska K, et al. Angiotensin 1\u20137 modulates molecular and cellular processes central to the pathogenesis of prostate cancer. Sci Rep. 2018;8(1):15772.","journal-title":"Sci Rep"},{"issue":"9","key":"2326_CR38","doi-asserted-by":"publisher","first-page":"H1171","DOI":"10.1152\/ajpheart.00897.2014","volume":"308","author":"JC Sullivan","year":"2015","unstructured":"Sullivan JC, et al. Differences in angiotensin (1\u20137) between men and women. Am J Physiol Heart Circ Physiol. 2015;308(9):H1171\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"2326_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0008-6363(01)00479-5","volume":"53","author":"M Fischer","year":"2002","unstructured":"Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53(3):672\u20137.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2326_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000099150","volume":"30","author":"BB McGuire","year":"2007","unstructured":"McGuire BB, et al. Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney. Kidney Blood Press Res. 2007;30(2):67\u201380.","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"2326_CR41","doi-asserted-by":"publisher","first-page":"R1220","DOI":"10.1152\/ajpregu.00864.2007","volume":"294","author":"JC Sullivan","year":"2008","unstructured":"Sullivan JC. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol. 2008;294(4):R1220\u20136.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"2326_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","volume":"95","author":"H Schunkert","year":"1997","unstructured":"Schunkert H, et al. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 1997;95(1):39\u201345.","journal-title":"Circulation"},{"key":"2326_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2019.106600","volume":"124","author":"M Fardoun","year":"2020","unstructured":"Fardoun M, et al. The hypertensive potential of estrogen: an untold story. Vascul Pharmacol. 2020;124:106600.","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"2326_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13578-023-00962-3","volume":"13","author":"M Wang","year":"2023","unstructured":"Wang M, Yang Y, Xu Y. Brain nuclear receptors and cardiovascular function. Cell Biosci. 2023;13(1):14.","journal-title":"Cell Biosci"},{"issue":"2","key":"2326_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/HYPERTENSIONAHA.122.17952","volume":"80","author":"CT Barris","year":"2023","unstructured":"Barris CT, Faulkner JL, Belin de Chantem\u00e8le EJ. Salt sensitivity of blood pressure in women. Hypertension. 2023;80(2):268\u201378.","journal-title":"Hypertension"},{"issue":"3","key":"2326_CR46","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000305","volume":"13","author":"A Vecchiola","year":"2024","unstructured":"Vecchiola A, et al. The role of sex hormones in aldosterone biosynthesis and their potential impact on its mineralocorticoid receptor. Cardiovasc Endocrinol Metab. 2024;13(3):e0305.","journal-title":"Cardiovasc Endocrinol Metab"},{"issue":"1","key":"2326_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.121.18425","volume":"79","author":"ME Hall","year":"2022","unstructured":"Hall ME, Hall JE. Sex differences in hypertension: related to genes, jean sizes, and salt sensitivity? Hypertension. 2022;79(1):47\u20139.","journal-title":"Hypertension"},{"issue":"24","key":"2326_CR48","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. 2021;385(24):2252\u201363.","journal-title":"N Engl J Med"},{"issue":"2","key":"2326_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","volume":"42","author":"R Agarwal","year":"2020","unstructured":"Agarwal R, et al. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur Heart J. 2020;42(2):152\u201361.","journal-title":"Eur Heart J"},{"issue":"4","key":"2326_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.genm.2012.06.001","volume":"9","author":"VF Rands","year":"2012","unstructured":"Rands VF, et al. Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II\u2212salt hypertension. Gend Med. 2012;9(4):207\u201318.","journal-title":"Gend Med"},{"issue":"6","key":"2326_CR51","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/ATVBAHA.112.248559","volume":"32","author":"M Gupte","year":"2012","unstructured":"Gupte M, et al. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL\/6 mice. Arterioscler Thromb Vasc Biol. 2012;32(6):1392\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2326_CR52","doi-asserted-by":"publisher","first-page":"H1770","DOI":"10.1152\/ajpheart.01011.2005","volume":"292","author":"B Xue","year":"2007","unstructured":"Xue B, et al. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol. 2007;292(4):H1770\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"2326_CR53","doi-asserted-by":"publisher","first-page":"H1025","DOI":"10.1152\/ajpheart.00021.2008","volume":"295","author":"B Xue","year":"2008","unstructured":"Xue B, et al. Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol. 2008;295(3):H1025-h1032.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"2326_CR54","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1161\/HYPERTENSIONAHA.111.00903","volume":"61","author":"B Xue","year":"2013","unstructured":"Xue B, et al. Estrogen receptor-\u03b2 in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone\/salt-induced hypertension in female rats. Hypertension. 2013;61(6):1255\u201362.","journal-title":"Hypertension"},{"key":"2326_CR55","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev.nutr.26.061505.111316","volume":"26","author":"KM O'Shaughnessy","year":"2006","unstructured":"O\u2019Shaughnessy KM, Karet FE. Salt handling and hypertension. Annu Rev Nutr. 2006;26:343\u201365.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"2326_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0002-9629(15)40679-2","volume":"319","author":"R Greger","year":"2000","unstructured":"Greger R. Physiology of renal sodium transport. Am J Med Sci. 2000;319(1):51\u201362.","journal-title":"Am J Med Sci"},{"issue":"4","key":"2326_CR57","doi-asserted-by":"publisher","first-page":"F849","DOI":"10.1152\/ajprenal.00181.2009","volume":"297","author":"PA Welling","year":"2009","unstructured":"Welling PA, Ho K. A comprehensive guide to the ROMK potassium channel: form and function in health and disease. Am J Physiol Renal Physiol. 2009;297(4):F849\u201363.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"2326_CR58","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/MNH.0b013e32832f2fcb","volume":"18","author":"B Ko","year":"2009","unstructured":"Ko B, Hoover RS. Molecular physiology of the thiazide-sensitive sodium-chloride cotransporter. Curr Opin Nephrol Hypertens. 2009;18(5):421\u20137.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"2326_CR59","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00424-022-02712-9","volume":"474","author":"E Feraille","year":"2022","unstructured":"Feraille E, et al. Renal water transport in health and disease. Pflugers Arch. 2022;474(8):841\u201352.","journal-title":"Pflugers Arch"},{"issue":"3\u20134","key":"2326_CR60","first-page":"198","volume":"10","author":"JD Horisberger","year":"1987","unstructured":"Horisberger JD, Giebisch G. Potassium-sparing diuretics. Ren Physiol. 1987;10(3\u20134):198\u2013220.","journal-title":"Ren Physiol"},{"key":"2326_CR61","unstructured":"Pirahanchi Y, Jessu R, Aeddula NR. Physiology, sodium potassium pump. In: StatPearls; 2025. StatPearls Publishing Copyright \u00a9 2025. StatPearls Publishing LLC: Treasure Island (FL)."},{"issue":"9","key":"2326_CR62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41569-025-01135-0","volume":"22","author":"SK Masenga","year":"2025","unstructured":"Masenga SK, et al. Salt sensitivity of blood pressure: mechanisms and sex-specific differences. Nat Rev Cardiol. 2025;22(9):611\u201328.","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"2326_CR63","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1681\/ASN.2017030295","volume":"28","author":"LC Veiras","year":"2017","unstructured":"Veiras LC, et al. Sexual dimorphic pattern of renal transporters and electrolyte homeostasis. J Am Soc Nephrol. 2017;28(12):3504\u201317.","journal-title":"J Am Soc Nephrol"},{"key":"2326_CR64","doi-asserted-by":"crossref","unstructured":"Li J, et al. Gender difference in kidney electrolyte transport. I. Role of AT(1a) receptor in thiazide-sensitive Na(+)-Cl(\u2212) cotransporter activity and expression in male and female mice. Am J Physiol Renal Physiol. 2017;313(2):F505\u2013F513.","DOI":"10.1152\/ajprenal.00087.2017"},{"issue":"8","key":"2326_CR65","doi-asserted-by":"publisher","first-page":"F799","DOI":"10.1152\/ajprenal.00447.2014","volume":"308","author":"L Rojas-Vega","year":"2015","unstructured":"Rojas-Vega L, et al. Ovarian hormones and prolactin increase renal NaCl cotransporter phosphorylation. Am J Physiol Renal Physiol. 2015;308(8):F799-808.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"2326_CR66","first-page":"F638","volume":"328","author":"AA McDonough","year":"2025","unstructured":"McDonough AA, et al. Effect of sex chromosome complement versus gonadal hormones on abundance of renal transporters. Am J Physiol Renal Physiol. 2025;328(5):F638\u201346.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2326_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41581-023-00757-2","volume":"20","author":"AA McDonough","year":"2024","unstructured":"McDonough AA, et al. Sex differences in renal transporters: assessment and functional consequences. Nat Rev Nephrol. 2024;20(1):21\u201336.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2326_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/HJH.0b013e328316bb87","volume":"27","author":"J He","year":"2009","unstructured":"He J, et al. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens. 2009;27(1):48\u201354.","journal-title":"J Hypertens"},{"issue":"12","key":"2326_CR69","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.7326\/0003-4819-135-12-200112180-00005","volume":"135","author":"WM Vollmer","year":"2001","unstructured":"Vollmer WM, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001;135(12):1019\u201328.","journal-title":"Ann Intern Med"},{"issue":"21","key":"2326_CR70","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMra2030212","volume":"385","author":"DH Ellison","year":"2021","unstructured":"Ellison DH, Welling P. Insights into salt handling and blood pressure. N Engl J Med. 2021;385(21):1981\u201393.","journal-title":"N Engl J Med"},{"issue":"5","key":"2326_CR71","doi-asserted-by":"publisher","first-page":"R945","DOI":"10.1152\/ajpregu.00363.2017","volume":"315","author":"P Bie","year":"2018","unstructured":"Bie P. Mechanisms of sodium balance: total body sodium, surrogate variables, and renal sodium excretion. Am J Physiol Regul Integr Comp Physiol. 2018;315(5):R945-r962.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"2326_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJM199007053230105","volume":"323","author":"A Panza Julio","year":"1990","unstructured":"Panza Julio A, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323(1):22\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"2326_CR73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bja\/aeh163","volume":"93","author":"HF Galley","year":"2004","unstructured":"Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth. 2004;93(1):105\u201313.","journal-title":"Br J Anaesth"},{"key":"2326_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2022.08.012","volume":"358","author":"T Sawma","year":"2022","unstructured":"Sawma T, et al. Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: implications for vascular function. Atherosclerosis. 2022;358:12\u201328.","journal-title":"Atherosclerosis"},{"issue":"8","key":"2326_CR75","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/CIRCULATIONAHA.124.071884","volume":"152","author":"J Wang","year":"2025","unstructured":"Wang J, et al. Inactivation of RhoA for hypertension treatment through the TRPV4-RhoA-RhoGDI1 axis. Circulation. 2025;152(8):519\u201336.","journal-title":"Circulation"},{"key":"2326_CR76","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger-Genge A, et al. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20(18).","DOI":"10.3390\/ijms20184411"},{"key":"2326_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117278","volume":"384","author":"J Robert","year":"2023","unstructured":"Robert J. Sex differences in vascular endothelial cells. Atherosclerosis. 2023;384:117278.","journal-title":"Atherosclerosis"},{"issue":"6","key":"2326_CR78","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/jcp.31019","volume":"238","author":"D Aboukhater","year":"2023","unstructured":"Aboukhater D, et al. Inflammation and hypertension: underlying mechanisms and emerging understandings. J Cell Physiol. 2023;238(6):1148\u201359.","journal-title":"J Cell Physiol"},{"key":"2326_CR79","doi-asserted-by":"publisher","unstructured":"Stachenfeld NS. Sex hormone effects on body fluid regulation. Exerc Sport Sci Rev. 2008;36(3):152\u2013159. https:\/\/doi.org\/10.1097\/JES.0b013e31817be928.","DOI":"10.1097\/JES.0b013e31817be928"},{"issue":"4","key":"2326_CR80","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1210\/jcem.85.4.6530","volume":"85","author":"NG Majmudar","year":"2000","unstructured":"Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab. 2000;85(4):1577\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2326_CR81","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1161\/01.HYP.30.6.1517","volume":"30","author":"M McIntyre","year":"1997","unstructured":"McIntyre M, et al. Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension. 1997;30(6):1517\u201324.","journal-title":"Hypertension"},{"issue":"4","key":"2326_CR82","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/01.HYP.28.4.576","volume":"28","author":"S Taddei","year":"1996","unstructured":"Taddei S, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28(4):576\u201382.","journal-title":"Hypertension"},{"issue":"1","key":"2326_CR83","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0895-7061(97)00360-9","volume":"11","author":"JF Reckelhoff","year":"1998","unstructured":"Reckelhoff JF, et al. Gender differences in the renal nitric oxide (NO) system*. Am J Hypertens. 1998;11(1):97\u2013104.","journal-title":"Am J Hypertens"},{"issue":"1","key":"2326_CR84","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.1038\/s41598-017-10139-x","volume":"7","author":"MG Cattaneo","year":"2017","unstructured":"Cattaneo MG, et al. Sex-specific eNOS activity and function in human endothelial cells. Sci Rep. 2017;7(1):9612.","journal-title":"Sci Rep"},{"issue":"9","key":"2326_CR85","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nri2394","volume":"8","author":"EN Fish","year":"2008","unstructured":"Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8(9):737\u201344.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2326_CR86","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"2 Suppl 2","key":"2326_CR87","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S3-23.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2326_CR88","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41371-021-00627-z","volume":"36","author":"JP Van Beusecum","year":"2022","unstructured":"Van Beusecum JP, Moreno H, Harrison DG. Innate immunity and clinical hypertension. J Hum Hypertens. 2022;36(6):503\u20139.","journal-title":"J Hum Hypertens"},{"issue":"2","key":"2326_CR89","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/01.CIR.0000105700.95607.49","volume":"109","author":"D Xing","year":"2004","unstructured":"Xing D, et al. Estradiol and progestins differentially modulate leukocyte infiltration after vascular injury. Circulation. 2004;109(2):234\u201341.","journal-title":"Circulation"},{"issue":"2","key":"2326_CR90","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","volume":"75","author":"AM Rothman","year":"2020","unstructured":"Rothman AM, et al. Effects of Interleukin-1\u03b2 inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS. Hypertension. 2020;75(2):477\u201382.","journal-title":"Hypertension"},{"issue":"4","key":"2326_CR91","doi-asserted-by":"publisher","first-page":"R1089","DOI":"10.1152\/ajpregu.00373.2009","volume":"298","author":"SD Crowley","year":"2010","unstructured":"Crowley SD, et al. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;298(4):R1089\u201397.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"2326_CR92","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1084\/jem.20171773","volume":"215","author":"AE Norlander","year":"2017","unstructured":"Norlander AE, Madhur MS, Harrison DG. The immunology of hypertension. J Exp Med. 2017;215(1):21\u201333.","journal-title":"J Exp Med"},{"issue":"6","key":"2326_CR93","doi-asserted-by":"publisher","first-page":"R407","DOI":"10.1152\/ajpregu.00304.2012","volume":"304","author":"DL Mattson","year":"2013","unstructured":"Mattson DL, et al. Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage. Am J Physiol Regul Integr Comp Physiol. 2013;304(6):R407\u201314.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"2326_CR94","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/HYPERTENSIONAHA.114.03581","volume":"64","author":"DP Pollow","year":"2014","unstructured":"Pollow DP, et al. Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension. 2014;64(2):384\u201390.","journal-title":"Hypertension"},{"issue":"3","key":"2326_CR95","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.114.03663","volume":"64","author":"H Ji","year":"2014","unstructured":"Ji H, et al. Sex-specific T-cell regulation of angiotensin II\u2013dependent hypertension. Hypertension. 2014;64(3):573\u201382.","journal-title":"Hypertension"},{"issue":"1-3","key":"2326_CR96","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12026-014-8548-6","volume":"59","author":"MV Singh","year":"2014","unstructured":"Singh MV, et al. The immune system and hypertension. Immunol Res. 2014;59(1\u20133):243\u201353.","journal-title":"Immunol Res"},{"issue":"2","key":"2326_CR97","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018038","volume":"10","author":"JA Uhlorn","year":"2021","unstructured":"Uhlorn JA, et al. CD4(+) T cell-specific proteomic pathways identified in progression of hypertension across postmenopausal transition. J Am Heart Assoc. 2021;10(2):e018038.","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"2326_CR98","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension: a review. JAMA. 2022;328(18):1849\u201361.","journal-title":"JAMA"},{"key":"2326_CR99","doi-asserted-by":"crossref","unstructured":"Kalibala J, Pech\u00e8re-Bertschi A, Desmeules J. Gender differences in cardiovascular pharmacotherapy\u2014the example of hypertension: a mini review. Front Pharmacol. 2020;11.","DOI":"10.3389\/fphar.2020.00564"},{"issue":"6-7","key":"2326_CR100","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ejheart.2007.02.001","volume":"9","author":"M Hudson","year":"2007","unstructured":"Hudson M, et al. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure\u2014a population study. Eur J Heart Fail. 2007;9(6\u20137):602\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2326_CR101","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10286-020-00720-2","volume":"30","author":"D Medina","year":"2020","unstructured":"Medina D, Mehay D, Arnold AC. Sex differences in cardiovascular actions of the renin-angiotensin system. Clin Auton Res. 2020;30(5):393\u2013408.","journal-title":"Clin Auton Res"},{"issue":"1","key":"2326_CR102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1524-6175.2001.990830.x","volume":"3","author":"MA Moore","year":"2001","unstructured":"Moore MA. Choosing initial antihypertensive drug therapy for the uncomplicated hypertensive patient. J Clin Hypertens (Greenwich). 2001;3(1):37\u201344.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"23","key":"2326_CR103","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/eurheartj\/ehac395","volume":"44","author":"L Lauder","year":"2023","unstructured":"Lauder L, et al. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023;44(23):2066\u201377.","journal-title":"Eur Heart J"},{"issue":"3","key":"2326_CR104","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/HJH.0000000000003901","volume":"43","author":"J Brguljan Hitij","year":"2025","unstructured":"Brguljan Hitij J, et al. Differences in sex and age response to single pill combination based antihypertensive therapy reflecting in blood pressure and arterial stiffness. J Hypertens. 2025;43(3):387\u201396.","journal-title":"J Hypertens"},{"issue":"1-4","key":"2326_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000365267","volume":"2","author":"J-Y Kim","year":"2014","unstructured":"Kim J-Y, et al. Gender difference in arterial stiffness in a multicenter cross-sectional study: the Korean Arterial Aging Study (KAAS). Pulse. 2014;2(1\u20134):11\u20137.","journal-title":"Pulse"},{"key":"2326_CR106","doi-asserted-by":"crossref","unstructured":"Vaes EWP, et al. Sex differences in the efficacy of diuretics in the treatment of hypertension; a systematic review and meta-analysis. Med Res Arch 2024;11(11).","DOI":"10.18103\/mra.v11i11.4269"},{"issue":"11","key":"2326_CR107","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/HYPERTENSIONAHA.124.22980","volume":"81","author":"W-J Yeo","year":"2024","unstructured":"Yeo W-J, et al. Sex differences in hypertension and its management throughout life. Hypertension. 2024;81(11):2263\u201374.","journal-title":"Hypertension"},{"issue":"11","key":"2326_CR108","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1161\/HYPERTENSIONAHA.123.21496","volume":"80","author":"Z Bidel","year":"2023","unstructured":"Bidel Z, et al. Sex-specific effects of blood pressure lowering pharmacotherapy for the prevention of cardiovascular disease: an individual participant-level data meta-analysis. Hypertension. 2023;80(11):2293\u2013302.","journal-title":"Hypertension"},{"issue":"5014","key":"2326_CR109","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1126\/science.2063193","volume":"252","author":"AC Guyton","year":"1991","unstructured":"Guyton AC. Blood pressure control\u2014special role of the kidneys and body fluids. Science. 1991;252(5014):1813\u20136.","journal-title":"Science"},{"issue":"Pt 5","key":"2326_CR110","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1258\/acb.2011.011281","volume":"49","author":"D Wile","year":"2012","unstructured":"Wile D. Diuretics: a review. Ann Clin Biochem. 2012;49(Pt 5):419\u201331.","journal-title":"Ann Clin Biochem"},{"key":"2326_CR111","doi-asserted-by":"publisher","unstructured":"Verlander JW, Tran TM, Zhang L, Kaplan MR, Hebert SC. Estradiol enhances thiazide-sensitive NaCl cotransporter density inthe apical plasma membrane of the distal convoluted tubule in ovariectomized rats. J Clin Invest. 1998;101(8):1661-9. https:\/\/doi.org\/10.1172\/JCI601.","DOI":"10.1172\/JCI601"},{"issue":"2","key":"2326_CR112","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0091270009337514","volume":"50","author":"U Werner","year":"2010","unstructured":"Werner U, et al. Gender is an important determinant of the disposition of the loop diuretic torasemide. J Clin Pharmacol. 2010;50(2):160\u20138.","journal-title":"J Clin Pharmacol"},{"key":"2326_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-141","volume":"11","author":"LM Brewster","year":"2013","unstructured":"Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and \u03b2-adrenergic blockers? A systematic review. BMC Med. 2013;11:141.","journal-title":"BMC Med"},{"issue":"19","key":"2326_CR114","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","volume":"341","author":"DR Abernethy","year":"1999","unstructured":"Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med. 1999;341(19):1447\u201357.","journal-title":"N Engl J Med"},{"issue":"2","key":"2326_CR115","doi-asserted-by":"publisher","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","volume":"286","author":"JM Orshal","year":"2004","unstructured":"Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004;286(2):R233\u201349.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2326_CR116","doi-asserted-by":"crossref","unstructured":"Kloner RA, et al. Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol. 1996;77(9):713\u201322.","DOI":"10.1016\/S0002-9149(97)89205-3"},{"issue":"6","key":"2326_CR117","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"3","key":"2326_CR118","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00005344-199509000-00018","volume":"26","author":"RA Kloner","year":"1995","unstructured":"Kloner RA, et al. Effect of amlodipine on left ventricular mass in the Amlodipine Cardiovascular Community Trial. J Cardiovasc Pharmacol. 1995;26(3):471\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"2326_CR119","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00005344-200405000-00018","volume":"43","author":"P Zapater","year":"2004","unstructured":"Zapater P, et al. Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. J Cardiovasc Pharmacol. 2004;43(5):737\u201344.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"2326_CR120","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1124\/pharmrev.120.000206","volume":"73","author":"F Mauvais-Jarvis","year":"2021","unstructured":"Mauvais-Jarvis F, et al. Sex- and gender-based pharmacological response to drugs. Pharmacol Rev. 2021;73(2):730\u201362.","journal-title":"Pharmacol Rev"},{"issue":"10205","key":"2326_CR121","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0140-6736(19)31792-1","volume":"394","author":"BT Santema","year":"2019","unstructured":"Santema BT, et al. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet. 2019;394(10205):1254\u201363.","journal-title":"Lancet"},{"issue":"1","key":"2326_CR122","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/dmd.112.046292","volume":"41","author":"T Cabaleiro","year":"2013","unstructured":"Cabaleiro T, et al. Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers. Drug Metab Dispos; 2013. 41(1) p224-229. https:\/\/doi.org\/10.1124\/dmd.112.046292.","journal-title":"Drug Metab Dispos"},{"issue":"23","key":"2326_CR123","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"M Massie Barry","year":"2008","unstructured":"Massie Barry M, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23):2456\u201367.","journal-title":"N Engl J Med"},{"key":"2326_CR124","doi-asserted-by":"crossref","unstructured":"Wiysonge CS, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017;1(1):Cd002003.","DOI":"10.1002\/14651858.CD002003.pub5"},{"key":"2326_CR125","doi-asserted-by":"crossref","unstructured":"Masarone D, et al. The use of \u03b2-Blockers in heart failure with reduced ejection fraction. J Cardiovasc Dev Dis. 2021;8(9).","DOI":"10.3390\/jcdd8090101"},{"issue":"6","key":"2326_CR126","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1053\/cp.1999.v66.103400001","volume":"66","author":"AB Luzier","year":"1999","unstructured":"Luzier AB, et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther. 1999;66(6):594\u2013601.","journal-title":"Clin Pharmacol Ther"},{"key":"2326_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/medsci4040018","author":"AR Eugene","year":"2016","unstructured":"Eugene AR. Metoprolol dose equivalence in adult men and women based on gender differences: pharmacokinetic modeling and simulations. Med Sci. 2016. https:\/\/doi.org\/10.3390\/medsci4040018.","journal-title":"Med Sci"},{"issue":"7456","key":"2326_CR128","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15\u20139.","journal-title":"BMJ"},{"key":"2326_CR129","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6904-7-9","volume":"7","author":"H Patel","year":"2007","unstructured":"Patel H, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998\u20132005. BMC Clin Pharmacol. 2007;7:9.","journal-title":"BMC Clin Pharmacol"},{"issue":"6","key":"2326_CR130","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/pds.5592","volume":"32","author":"LC Hendriksen","year":"2023","unstructured":"Hendriksen LC, et al. Women on diuretics have a higher risk of hospital admission because of hyponatremia than men. Pharmacoepidemiol Drug Saf. 2023;32(6):635\u201342.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"2326_CR131","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00228-018-2480-y","volume":"74","author":"DM Rydberg","year":"2018","unstructured":"Rydberg DM, et al. Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs. Eur J Clin Pharmacol. 2018;74(9):1165\u201373.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"2326_CR132","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40264-025-01564-3","volume":"48","author":"N Maida","year":"2025","unstructured":"Maida N, et al. Sex differences in electrolyte disturbances among diuretic users according to renal function and age. Drug Saf. 2025;48(10):1149\u201359.","journal-title":"Drug Saf"},{"key":"2326_CR133","doi-asserted-by":"crossref","unstructured":"Sica D. Calcium channel blocker-related periperal edema: can it be resolved? J Clin Hypertens (Greenwich), 2003;5(4):291\u20134, 297.","DOI":"10.1111\/j.1524-6175.2003.02402.x"},{"issue":"8","key":"2326_CR134","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/jhh.2008.157","volume":"23","author":"A de la Sierra","year":"2009","unstructured":"de la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens. 2009;23(8):503\u201311.","journal-title":"J Hum Hypertens"},{"issue":"12","key":"2326_CR135","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.18425","volume":"2","author":"SM Vouri","year":"2019","unstructured":"Vouri SM, et al. Magnitude of and characteristics associated with the treatment of calcium channel blocker-induced lower-extremity edema with loop diuretics. JAMA Netw Open. 2019;2(12):e1918425.","journal-title":"JAMA Netw Open"},{"issue":"sup2","key":"2326_CR136","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14740338.2016.1225720","volume":"15","author":"L Sportiello","year":"2016","unstructured":"Sportiello L, et al. No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region. Expert Opin Drug Saf. 2016;15(sup2):101\u20137.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"2326_CR137","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8224","volume":"5","author":"SH Bots","year":"2022","unstructured":"Bots SH, et al. Sex differences in reported adverse drug reactions to angiotensin-converting enzyme inhibitors. JAMA Netw Open. 2022;5(4):e228224.","journal-title":"JAMA Netw Open"},{"key":"2326_CR138","doi-asserted-by":"crossref","unstructured":"Rossello X, et al. Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial. Eur Heart J. 2025.","DOI":"10.1093\/eurheartj\/ehaf673"},{"issue":"10","key":"2326_CR139","first-page":"1633","volume":"36","author":"CA Jackevicius","year":"2020","unstructured":"Jackevicius CA, et al. Clinical outcomes with beta-blocker use in patients with recent history of myocardial infarction. Can J Cardiol. 2020;36(10):1633\u201340.","journal-title":"Can J Cardiol"},{"issue":"2","key":"2326_CR140","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00006842-199803000-00006","volume":"60","author":"K Kroenke","year":"1998","unstructured":"Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med. 1998;60(2):150\u20135.","journal-title":"Psychosom Med"},{"issue":"3","key":"2326_CR141","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0002-9343(89)90293-3","volume":"86","author":"K Kroenke","year":"1989","unstructured":"Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86(3):262\u20136.","journal-title":"Am J Med"},{"issue":"2","key":"2326_CR142","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1161\/HYPERTENSIONAHA.116.07575","volume":"68","author":"BM Egan","year":"2016","unstructured":"Egan BM, Li J, Wagner CS. Systolic Blood Pressure Intervention Trial (SPRINT) and target systolic blood pressure in future hypertension guidelines. Hypertension. 2016;68(2):318\u201323.","journal-title":"Hypertension"},{"issue":"3","key":"2326_CR143","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11906-014-0419-y","volume":"16","author":"JB Byrd","year":"2014","unstructured":"Byrd JB, Bakris G, Jamerson K. The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension. Curr Hypertens Rep. 2014;16(3):419.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"2326_CR144","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12304","volume":"13","author":"E Miller","year":"2023","unstructured":"Miller E, et al. Differential drug response in pulmonary arterial hypertension: the potential for precision medicine. Pulm Circ. 2023;13(4):e12304.","journal-title":"Pulm Circ"},{"key":"2326_CR145","unstructured":"Marino M, Jamal Z, Zito PM. Pharmacodynamics. In: StatPearls. 2024; StatPearls Publishing. Copyright \u00a9 2024, StatPearls Publishing LLC: Treasure Island (FL)"},{"key":"2326_CR146","doi-asserted-by":"crossref","unstructured":"Fenech AG, Petroni Magri V. Gender differences in drug therapy. In: Hock FJ, Gralinski MR, editors. drug discovery and evaluation: methods in clinical pharmacology. Springer International Publishing: Cham; 2019. p. 1\u201324.","DOI":"10.1007\/978-3-319-56637-5_69-1"},{"issue":"6","key":"2326_CR147","first-page":"259","volume":"12","author":"M Khajedaluee","year":"2016","unstructured":"Khajedaluee M, et al. The prevalence of hypertension and its relationship with demographic factors, biochemical, and anthropometric indicators: a population-based study. ARYA Atheroscler. 2016;12(6):259\u201365.","journal-title":"ARYA Atheroscler"},{"issue":"4","key":"2326_CR148","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7326\/M22-1510","volume":"176","author":"JB Segal","year":"2023","unstructured":"Segal JB, et al. Assessing heterogeneity of treatment effect in real-world data. Ann Intern Med. 2023;176(4):536\u201344.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2326_CR149","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bcp.2013.09.007","volume":"87","author":"J Fan","year":"2014","unstructured":"Fan J, de Lannoy IA. Pharmacokinetics. Biochem Pharmacol. 2014;87(1):93\u2013120.","journal-title":"Biochem Pharmacol"},{"key":"2326_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(08)00001-9","volume":"83","author":"GD Anderson","year":"2008","unstructured":"Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008;83:1\u201310.","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"2326_CR151","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.121.17796","volume":"78","author":"A Kauko","year":"2021","unstructured":"Kauko A, et al. Sex differences in genetic risk for hypertension. Hypertension. 2021;78(4):1153\u20135.","journal-title":"Hypertension"},{"issue":"2","key":"2326_CR152","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ajh\/hpy168","volume":"32","author":"B Rodriguez-Iturbe","year":"2019","unstructured":"Rodriguez-Iturbe B, Johnson RJ. Genetic polymorphisms in hypertension: are we missing the immune connection? Am J Hypertens. 2019;32(2):113\u201322.","journal-title":"Am J Hypertens"},{"issue":"1","key":"2326_CR153","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40246-018-0175-1","volume":"12","author":"Y Jin","year":"2018","unstructured":"Jin Y, et al. Architecture of polymorphisms in the human genome reveals functionally important and positively selected variants in immune response and drug transporter genes. Hum Genomics. 2018;12(1):43.","journal-title":"Hum Genomics"},{"issue":"1","key":"2326_CR154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295626","volume":"19","author":"X Jia","year":"2024","unstructured":"Jia X, et al. Impact of the gene polymorphisms in the Renin-Angiotensin System on cardiomyopathy risk: a meta-analysis. PLoS ONE. 2024;19(1):e0295626.","journal-title":"PLoS ONE"},{"issue":"2","key":"2326_CR155","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.atherosclerosis.2005.11.008","volume":"188","author":"MS Islam","year":"2006","unstructured":"Islam MS, et al. Polymorphism of the angiotensin-converting enzyme (ACE) and angiotesinogen (AGT) genes and their associations with blood pressure and carotid artery intima media thickness among healthy Finnish young adults\u2014the Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2006;188(2):316\u201322.","journal-title":"Atherosclerosis"},{"issue":"3","key":"2326_CR156","doi-asserted-by":"publisher","first-page":"399","DOI":"10.18433\/J3KW3B","volume":"15","author":"K Srivastava","year":"2012","unstructured":"Srivastava K, et al. Association of angiotensinogen (M235T) gene polymorphism with blood pressure lowering response to Angiotensin converting enzyme inhibitor (Enalapril). J Pharm Pharm Sci. 2012;15(3):399\u2013406.","journal-title":"J Pharm Pharm Sci"},{"key":"2326_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2019.100421","volume":"16","author":"JK Fajar","year":"2019","unstructured":"Fajar JK, et al. The genes polymorphism of angiotensinogen (AGT) M235T and AGT T174M in patients with essential hypertension: a meta-analysis. Gene Rep. 2019;16:100421.","journal-title":"Gene Rep"},{"key":"2326_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12121291","author":"M Shahid","year":"2022","unstructured":"Shahid M, et al. Genetic polymorphism in angiotensinogen and its association with cardiometabolic diseases. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12121291.","journal-title":"Metabolites"},{"key":"2326_CR159","doi-asserted-by":"publisher","first-page":"1695769","DOI":"10.1155\/2022\/1695769","volume":"2022","author":"S Thakur","year":"2022","unstructured":"Thakur S, et al. Angiotensin-converting enzyme (ACE) insertion\/deletion (I\/D) polymorphism as a conjoint regulator of coagulation, fibrinolytic, and RAAS pathway in infertility and associated pregnancy complications. J Renin Angiotensin Aldosterone Syst. 2022;2022:1695769.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"25","key":"2326_CR160","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1161\/CIRCULATIONAHA.104.504639","volume":"111","author":"DK Arnett","year":"2005","unstructured":"Arnett DK, et al. Pharmacogenetic association of the angiotensin-converting enzyme insertion\/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Circulation. 2005;111(25):3374\u201383.","journal-title":"Circulation"},{"issue":"1","key":"2326_CR161","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00439-007-0370-y","volume":"122","author":"AI Lynch","year":"2007","unstructured":"Lynch AI, et al. Sex-specific effects of ACE I\/D and AGT-M235T on pulse pressure: the HyperGEN study. Hum Genet. 2007;122(1):33\u201340.","journal-title":"Hum Genet"},{"issue":"3","key":"2326_CR162","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1291\/hypres.25.481","volume":"25","author":"L Gesang","year":"2002","unstructured":"Gesang L, et al. Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population. Hypertens Res. 2002;25(3):481\u20135.","journal-title":"Hypertens Res"},{"issue":"11","key":"2326_CR163","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1097\/00004872-200411000-00016","volume":"22","author":"S Gardier","year":"2004","unstructured":"Gardier S, et al. A1166C polymorphism of angiotensin II type 1 receptor, blood pressure and arterial stiffness in hypertension. J Hypertens. 2004;22(11):2135\u201342.","journal-title":"J Hypertens"},{"issue":"3","key":"2326_CR164","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ihj.2015.04.013","volume":"67","author":"A Mishra","year":"2015","unstructured":"Mishra A, et al. Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction. Indian Heart J. 2015;67(3):214\u201321.","journal-title":"Indian Heart J"},{"issue":"4","key":"2326_CR165","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/1470320311405873","volume":"12","author":"B Sun","year":"2011","unstructured":"Sun B, et al. Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. J Renin Angiotensin Aldosterone Syst. 2011;12(4):564\u201371.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"12","key":"2326_CR166","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/jhh.2016.24","volume":"30","author":"YY Chen","year":"2016","unstructured":"Chen YY, et al. Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors. J Hum Hypertens. 2016;30(12):766\u201371.","journal-title":"J Hum Hypertens"},{"issue":"2","key":"2326_CR167","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1530\/JOE-18-0247","volume":"240","author":"Y Huang","year":"2019","unstructured":"Huang Y, et al. Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production. J Endocrinol. 2019;240(2):111\u201322.","journal-title":"J Endocrinol"},{"issue":"5","key":"2326_CR168","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/clinem\/dgac011","volume":"107","author":"WW Parksook","year":"2022","unstructured":"Parksook WW, et al. Salt sensitivity of blood pressure and aldosterone: interaction between the lysine-specific demethylase 1 gene, sex, and age. J Clin Endocrinol Metab. 2022;107(5):1294\u2013302.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2326_CR169","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41440-022-00859-7","volume":"45","author":"N Kohata","year":"2022","unstructured":"Kohata N, et al. Lysine-specific demethylase 1 as a corepressor of mineralocorticoid receptor. Hypertens Res. 2022;45(4):641\u20139.","journal-title":"Hypertens Res"},{"issue":"12","key":"2326_CR170","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s11010-024-04947-9","volume":"479","author":"S Yaacoub","year":"2024","unstructured":"Yaacoub S, et al. The pharmaco-epigenetics of hypertension: a focus on microRNA. Mol Cell Biochem. 2024;479(12):3255\u201371.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"2326_CR171","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/bph.17414","volume":"182","author":"J El Cheikh","year":"2025","unstructured":"El Cheikh J, et al. Genetic polymorphisms influencing antihypertensive drug responses. Br J Pharmacol. 2025;182(4):929\u201350.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2326_CR172","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trsl.2014.06.007","volume":"165","author":"S Friso","year":"2015","unstructured":"Friso S, et al. Epigenetics and arterial hypertension: the challenge of emerging evidence. Transl Res. 2015;165(1):154\u201365.","journal-title":"Transl Res"},{"issue":"6","key":"2326_CR173","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/HYPERTENSIONAHA.118.11171","volume":"72","author":"M Liang","year":"2018","unstructured":"Liang M. Epigenetic mechanisms and hypertension. Hypertension. 2018;72(6):1244\u201354.","journal-title":"Hypertension"},{"issue":"2","key":"2326_CR174","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/HYPERTENSIONAHA.123.21755","volume":"81","author":"A Ray","year":"2024","unstructured":"Ray A, et al. Histone modifications and their contributions to hypertension. Hypertension. 2024;81(2):229\u201339.","journal-title":"Hypertension"},{"issue":"4","key":"2326_CR175","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/ijms17040451","volume":"17","author":"IA Wise","year":"2016","unstructured":"Wise IA, Charchar FJ. Epigenetic modifications in essential hypertension. Int J Mol Sci. 2016;17(4):451.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2326_CR176","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-022-01055-2","volume":"7","author":"Y Shi","year":"2022","unstructured":"Shi Y, et al. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2022;7(1):200.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"2326_CR177","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1139\/cjpp-2023-0406","volume":"102","author":"C Thej","year":"2024","unstructured":"Thej C, Kishore R. Epigenetic regulation of sex dimorphism in cardiovascular health. Can J Physiol Pharmacol. 2024;102(9):498\u2013510.","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"2326_CR178","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13293-018-0180-z","volume":"9","author":"RJG Hartman","year":"2018","unstructured":"Hartman RJG, Huisman SE, den Ruijter HM. Sex differences in cardiovascular epigenetics\u2014a systematic review. Biol Sex Differ. 2018;9(1):19.","journal-title":"Biol Sex Differ"},{"issue":"1","key":"2326_CR179","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41467-024-45295-y","volume":"15","author":"Y Yan","year":"2024","unstructured":"Yan Y, et al. Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development. Nat Commun. 2024;15(1):873.","journal-title":"Nat Commun"},{"issue":"10","key":"2326_CR180","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrneph.2012.191","volume":"8","author":"HM Wadei","year":"2012","unstructured":"Wadei HM, Textor SC. The role of the kidney in regulating arterial blood pressure. Nat Rev Nephrol. 2012;8(10):602\u20139.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2326_CR181","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jacbts.2020.11.013","volume":"6","author":"DE Soranno","year":"2021","unstructured":"Soranno DE, et al. Acute kidney injury results in long-term diastolic dysfunction that is prevented by histone deacetylase inhibition. JACC Basic Transl Sci. 2021;6(2):119\u201333.","journal-title":"JACC Basic Transl Sci"},{"key":"2326_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020276","author":"CE Condrat","year":"2020","unstructured":"Condrat CE, et al. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9020276.","journal-title":"Cells"},{"issue":"4","key":"2326_CR183","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032433","volume":"13","author":"LMS Chekka","year":"2024","unstructured":"Chekka LMS, et al. Circulating microRNA biomarkers of thiazide response in hypertension. J Am Heart Assoc. 2024;13(4):e032433.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"2326_CR184","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1080\/15592294.2022.2038418","volume":"17","author":"ML Nuotio","year":"2022","unstructured":"Nuotio ML, et al. Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study design. Epigenetics. 2022;17(11):1432\u201345.","journal-title":"Epigenetics"},{"issue":"6","key":"2326_CR185","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.gendis.2022.04.007","volume":"9","author":"J Li","year":"2022","unstructured":"Li J, et al. Long noncoding RNA XIST: mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities. Genes Dis. 2022;9(6):1478\u201392.","journal-title":"Genes Dis"},{"key":"2326_CR186","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0330-2020","author":"C Cheron","year":"2021","unstructured":"Cheron C, et al. Sex and gender in pulmonary arterial hypertension. Eur Respir Rev. 2021. https:\/\/doi.org\/10.1183\/16000617.0330-2020.","journal-title":"Eur Respir Rev"},{"key":"2326_CR187","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.vph.2016.02.002","volume":"82","author":"MA Anwar","year":"2016","unstructured":"Anwar MA, et al. Glucocorticoid-induced fetal origins of adult hypertension: association with epigenetic events. Vascul Pharmacol. 2016;82:41\u201350.","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"2326_CR188","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143\u201357.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2326_CR189","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","volume":"11","author":"I Zucker","year":"2020","unstructured":"Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020;11(1):32.","journal-title":"Biol Sex Differ"},{"issue":"7","key":"2326_CR190","first-page":"1204","volume":"28","author":"FL Datz","year":"1987","unstructured":"Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med. 1987;28(7):1204\u20137.","journal-title":"J Nucl Med"},{"key":"2326_CR191","doi-asserted-by":"crossref","unstructured":"Mandi\u0107-Kovacevi\u0107 N, et al. Study of the acidic, basic, and thermal degradation kinetics of three antihypertensive drugs-individually and in combination. Pharmaceutics. 2024;16(11).","DOI":"10.3390\/pharmaceutics16111410"},{"issue":"1","key":"2326_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","volume":"21","author":"OA Almazroo","year":"2017","unstructured":"Almazroo OA, et al., Drug metabolism in the liver. Clin Liver Dis. 2017;21(1):1\u201320. https:\/\/doi.org\/10.1016\/j.cld.2016.08.001.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"2326_CR193","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11906-023-01244-6","volume":"25","author":"P Bardhan","year":"2023","unstructured":"Bardhan P, Yang T. Sexual dimorphic interplays between gut microbiota and antihypertensive drugs. Curr Hypertens Rep. 2023;25(8):163\u201372.","journal-title":"Curr Hypertens Rep"},{"key":"2326_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312808","author":"M Zhao","year":"2021","unstructured":"Zhao M, et al. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222312808.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2326_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09777","volume":"8","author":"J Ahmed II","year":"2022","unstructured":"Ahmed J II, et al. P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease. Heliyon. 2022;8(6):e09777.","journal-title":"Heliyon"},{"issue":"10","key":"2326_CR196","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1111\/bcp.14049","volume":"85","author":"I Ali","year":"2019","unstructured":"Ali I, et al. Impact of reduced P-glycoprotein function on digoxin concentrations in patients with dementia. Br J Clin Pharmacol. 2019;85(10):2351\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"2326_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071103","author":"TT Nguyen","year":"2021","unstructured":"Nguyen TT, Duong VA, Maeng HJ. Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13071103.","journal-title":"Pharmaceutics"},{"key":"2326_CR198","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13293-015-0020-3","volume":"6","author":"S Joseph","year":"2015","unstructured":"Joseph S, et al. Expression of drug transporters in human kidney: impact of sex, age, and ethnicity. Biol Sex Differ. 2015;6:4.","journal-title":"Biol Sex Differ"},{"issue":"7","key":"2326_CR199","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11906-018-0856-0","volume":"20","author":"EY Gohar","year":"2018","unstructured":"Gohar EY, Pollock DM. Sex-specific contributions of endothelin to hypertension. Curr Hypertens Rep. 2018;20(7):58.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"2326_CR200","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1042\/CS20070169","volume":"114","author":"RC Tostes","year":"2007","unstructured":"Tostes RC, et al. Endothelin, sex and hypertension. Clin Sci Lond. 2007;114(2):85\u201397.","journal-title":"Clin Sci Lond"},{"issue":"1","key":"2326_CR201","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/bbrc.1998.9409","volume":"251","author":"M Akishita","year":"1998","unstructured":"Akishita M, et al. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor. Biochem Biophys Res Commun. 1998;251(1):17\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2326_CR202","doi-asserted-by":"publisher","first-page":"285","DOI":"10.7326\/0003-4819-128-4-199802150-00006","volume":"128","author":"PJM Best","year":"1998","unstructured":"Best PJM, et al. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med. 1998;128(4):285\u20138.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2326_CR203","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/01.HYP.37.2.640","volume":"37","author":"RK Dubey","year":"2001","unstructured":"Dubey RK, et al. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension. 2001;37(2):640\u20134.","journal-title":"Hypertension"},{"key":"2326_CR204","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mce.2016.06.018","volume":"434","author":"A Pedram","year":"2016","unstructured":"Pedram A, et al. Estrogen receptor beta signals to inhibition of cardiac fibrosis. Mol Cell Endocrinol. 2016;434:57\u201368.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2326_CR205","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1378\/chest.11-0404","volume":"141","author":"NB Gabler","year":"2012","unstructured":"Gabler NB, et al. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. Chest. 2012;141(1):20\u20136.","journal-title":"Chest"},{"issue":"10","key":"2326_CR206","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015110","volume":"9","author":"EY Gohar","year":"2020","unstructured":"Gohar EY, et al. Evidence for G-protein\u2013coupled estrogen receptor as a pronatriuretic factor. J Am Heart Assoc. 2020;9(10):e015110.","journal-title":"J Am Heart Assoc"},{"key":"2326_CR207","doi-asserted-by":"crossref","unstructured":"Insel Paul A. Adrenergic receptors\u2014evolving concepts and clinical implications. N Engl J Med. 334(9):580\u201385.","DOI":"10.1056\/NEJM199602293340907"},{"issue":"3","key":"2326_CR208","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ando.2020.03.012","volume":"82","author":"J Motiejunaite","year":"2021","unstructured":"Motiejunaite J, Amar L, Vidal-Petiot E. Adrenergic receptors and cardiovascular effects of catecholamines. Ann Endocrinol Paris. 2021;82(3):193\u20137.","journal-title":"Ann Endocrinol Paris"},{"key":"2326_CR209","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","volume":"124","author":"S Laurent","year":"2017","unstructured":"Laurent S. Antihypertensive drugs. Pharmacol Res. 2017;124:116\u201325.","journal-title":"Pharmacol Res"},{"key":"2326_CR210","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.neubiorev.2016.04.018","volume":"74","author":"SK Wood","year":"2017","unstructured":"Wood SK, Valentino RJ. The brain norepinephrine system, stress and cardiovascular vulnerability. Neurosci Biobehav Rev. 2017;74:393\u2013400.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"2326_CR211","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41386-018-0137-2","volume":"44","author":"DA Bangasser","year":"2019","unstructured":"Bangasser DA, Eck SR, Ordo\u00f1es Sanchez E. Sex differences in stress reactivity in arousal and attention systems. Neuropsychopharmacology. 2019;44(1):129\u201339.","journal-title":"Neuropsychopharmacology"},{"key":"2326_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/biology11050653","author":"T Murakami","year":"2022","unstructured":"Murakami T, et al. Gender differences in Takotsubo syndrome. Biol Basel. 2022. https:\/\/doi.org\/10.3390\/biology11050653.","journal-title":"Biol Basel"},{"issue":"1","key":"2326_CR213","doi-asserted-by":"publisher","first-page":"H256","DOI":"10.1152\/ajpheart.2002.282.1.H256","volume":"282","author":"VM Vizgirda","year":"2002","unstructured":"Vizgirda VM, et al. Mechanisms of sex differences in rat cardiac myocyte response to \u03b2-adrenergic stimulation. Am J Physiol-Heart Circ Physiol. 2002;282(1):H256\u201363.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"4","key":"2326_CR214","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0735-1097(00)00849-4","volume":"36","author":"BJ Kneale","year":"2000","unstructured":"Kneale BJ, et al. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol. 2000;36(4):1233\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2326_CR215","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00395-017-0617-2","volume":"112","author":"S Al-Gburi","year":"2017","unstructured":"Al-Gburi S, et al. Sex-difference in expression and function of beta-adrenoceptors in macrovessels: role of the endothelium. Basic Res Cardiol. 2017;112(3):29.","journal-title":"Basic Res Cardiol"},{"key":"2326_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040771","author":"SH Jeong","year":"2022","unstructured":"Jeong SH, et al. Population pharmacokinetic (Pop-PK) analysis of torsemide in healthy Korean males considering CYP2C9 and OATP1B1 genetic polymorphisms. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14040771.","journal-title":"Pharmaceutics"},{"issue":"4","key":"2326_CR217","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1681\/ASN.V541112","volume":"5","author":"Z Chen","year":"1994","unstructured":"Chen Z, Vaughn DA, Fanestil DD. Influence of gender on renal thiazide diuretic receptor density and response. J Am Soc Nephrol. 1994;5(4):1112\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2326_CR218","doi-asserted-by":"publisher","first-page":"F1116","DOI":"10.1152\/ajprenal.00741.2010","volume":"300","author":"KV Juul","year":"2011","unstructured":"Juul KV, et al. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol. 2011;300(5):F1116\u201322.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2326_CR219","doi-asserted-by":"crossref","unstructured":"Vaes E. Sex differences in the efficacy of diuretics in the treatment of hypertension; a systematic review and meta-analysis. Med Res Arch. 2023;11(11).","DOI":"10.18103\/mra.v11i11.4269"},{"issue":"5","key":"2326_CR220","doi-asserted-by":"publisher","first-page":"F737","DOI":"10.1152\/ajprenal.00398.2023","volume":"326","author":"K Zheng","year":"2024","unstructured":"Zheng K, Layton AT. Predicting sex differences in the effects of diuretics in renal epithelial transport during angiotensin II-induced hypertension. Am J Physiol Renal Physiol. 2024;326(5):F737\u201350.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2326_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1409271","volume":"15","author":"LC Hendriksen","year":"2024","unstructured":"Hendriksen LC, et al. Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics. Front Pharmacol. 2024;15:1409271.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2326_CR222","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1524-6175.2004.01696.x","volume":"6","author":"I Hajjar","year":"2004","unstructured":"Hajjar I, Graves JW. Hyponatremia in older women. J Clin Hypertens (Greenwich). 2004;6(1):37\u20139.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"2326_CR223","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2710.1999.00246.x","volume":"24","author":"E Tanaka","year":"1999","unstructured":"Tanaka E. Gender-related differences in pharmacokinetics and their clinical significance. J Clin Pharm Ther. 1999;24(5):339\u201346.","journal-title":"J Clin Pharm Ther"},{"key":"2326_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107891","volume":"229","author":"J Tamargo","year":"2022","unstructured":"Tamargo J, Caballero R, Delp\u00f3n E. Sex-related differences in the pharmacological treatment of heart failure. Pharmacol Ther. 2022;229:107891.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"2326_CR225","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1152\/jappl.2001.91.6.2503","volume":"91","author":"DK Bowles","year":"2001","unstructured":"Bowles DK. Gender influences coronary L-type Ca2+current and adaptation to exercise training in miniature swine. J Appl Physiol. 2001;91(6):2503\u201310.","journal-title":"J Appl Physiol"},{"issue":"23","key":"2326_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233850","volume":"11","author":"YD Subbamanda","year":"2022","unstructured":"Subbamanda YD, Bhargava A. Intercommunication between voltage-gated calcium channels and estrogen receptor\/estrogen signaling: insights into physiological and pathological conditions. Cells. 2022;11(23):3850.","journal-title":"Cells"},{"issue":"5","key":"2326_CR227","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.phrs.2004.11.006","volume":"51","author":"F Abad-Santos","year":"2005","unstructured":"Abad-Santos F, et al. Assessment of sex differences in pharmacokinetics and pharmacodynamics of amlodipine in a bioequivalence study. Pharmacol Res. 2005;51(5):445\u201352.","journal-title":"Pharmacol Res"},{"key":"2326_CR228","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1038\/s41440-025-02400-y","volume":"48","author":"S Choopani","year":"2025","unstructured":"Choopani, S., Nematbakhsh, M. The relationship between estrogen and renin angiotensin system components in the context of hypertension. Hypertens Res. 2025; 48, 3147\u20133158. https:\/\/doi.org\/10.1038\/s41440-025-02400-y.","journal-title":"Hypertens Res"},{"issue":"3","key":"2326_CR229","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ehjcvp\/pvw042","volume":"3","author":"J Tamargo","year":"2017","unstructured":"Tamargo J, et al. Gender differences in the effects of cardiovascular drugs. Eur Heart J Cardiovasc Pharmacother. 2017;3(3):163\u201382.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"8","key":"2326_CR230","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/jch.14695","volume":"25","author":"Y Hu","year":"2023","unstructured":"Hu Y, et al. Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: a systematic review, and network meta-analysis. J Clin Hypertens (Greenwich). 2023;25(8):661\u201388.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"18","key":"2326_CR231","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1042\/CS20160261","volume":"130","author":"U Panchapakesan","year":"2016","unstructured":"Panchapakesan U, Pollock C. Long non-coding RNAs\u2014towards precision medicine in diabetic kidney disease? Clin Sci. 2016;130(18):1599\u2013602.","journal-title":"Clin Sci"},{"issue":"4","key":"2326_CR232","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/cpt.1928","volume":"108","author":"P Hirvensalo","year":"2020","unstructured":"Hirvensalo P, et al. UGT1A3 and sex are major determinants of telmisartan pharmacokinetics-a comprehensive pharmacogenomic study. Clin Pharmacol Ther. 2020;108(4):885\u201395.","journal-title":"Clin Pharmacol Ther"},{"key":"2326_CR233","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00564","author":"J Kalibala","year":"2020","unstructured":"Kalibala J, Pech\u00e8re-Bertschi A, Desmeules J. Gender differences in cardiovascular pharmacotherapy\u2014the example of hypertension: a mini review. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.00564.","journal-title":"Front Pharmacol"},{"key":"2326_CR234","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154280","author":"D Liccardo","year":"2022","unstructured":"Liccardo D, et al. Sex\/gender- and age-related differences in \u03b2-adrenergic receptor signaling in cardiovascular diseases. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11154280.","journal-title":"J Clin Med"},{"key":"2326_CR235","unstructured":"Rossello X, et al. Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial. Eur Heart J. 2025:ehaf673."},{"key":"2326_CR236","doi-asserted-by":"crossref","unstructured":"Abdelhamid A, et al. The emerging role of artificial intelligence in drug discovery and development: implications for cardiovascular pharmacology. J Cardiovasc Pharmacol. 2026.","DOI":"10.1097\/FJC.0000000000001803"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02326-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:02:19Z","timestamp":1784203339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-026-02326-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":236,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2326"],"URL":"https:\/\/doi.org\/10.1007\/s40265-026-02326-w","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Serge Yaacoub, Charles Bardawil, Ryan Yammine, Ali H. Dakroub, and Ali H. Eid declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing is not applicable to this article as no datasets were generated for this manuscript.","order":3,"name":"Ethics","label":"Data availability statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization: AHE. Analysis: AHE. Supervision: AHE. Validation: SY and AHD. Visualization: AHD and AHE. Writing\u2014original draft: SY, CB, RY, and AHE. Writing\u2014reviewing and editing: AHD and AHE. Project administration: AHE.","order":7,"name":"Ethics","label":"Authors contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}